PL1768657T3 - Sposoby i kompozycje do leczenia stanów ocznych za pomocą pochodnych retinylowych - Google Patents

Sposoby i kompozycje do leczenia stanów ocznych za pomocą pochodnych retinylowych

Info

Publication number: PL1768657T3
Authority: PL; Poland
Prior art keywords: retinyl; derivates; compositions; methods; ophthalmic conditions
Prior art date: 2004-06-23

Application number

PL05758777T

Other languages

English (en)

Inventor

Kenneth Widder

Jay Lichter

Nathan L Mata

Original Assignee

Revision Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-23

Filing date

2005-06-06

Publication date

2009-01-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34981643&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1768657(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-06-06 Application filed by Revision Therapeutics Inc filed Critical Revision Therapeutics Inc

2009-01-30 Publication of PL1768657T3 publication Critical patent/PL1768657T3/pl

Links

239000000203 mixture Substances 0.000 title 1
125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
- G01N2800/164—Retinal disorders, e.g. retinopathy

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Ophthalmology & Optometry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL05758777T 2004-06-23 2005-06-06 Sposoby i kompozycje do leczenia stanów ocznych za pomocą pochodnych retinylowych PL1768657T3 (pl)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US58229304P	2004-06-23	2004-06-23
US62969504P	2004-11-19	2004-11-19
US66090405P	2005-03-11	2005-03-11
US67240505P	2005-04-18	2005-04-18
PCT/US2005/020080 WO2006007314A1 (en)	2004-06-23	2005-06-06	Methods and compositions for treating ophthalmic conditions with retinyl derivatives
EP05758777A EP1768657B1 (en)	2004-06-23	2005-06-06	Methods and compositions for treating ophthalmic conditions with retinyl derivates

Publications (1)

Publication Number	Publication Date
PL1768657T3 true PL1768657T3 (pl)	2009-01-30

Family

ID=34981643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05758777T PL1768657T3 (pl)	2004-06-23	2005-06-06	Sposoby i kompozycje do leczenia stanów ocznych za pomocą pochodnych retinylowych

Country Status (26)

Country	Link
US (3)	US8314152B2 (pl)
EP (3)	EP1768657B1 (pl)
JP (1)	JP4855396B2 (pl)
KR (1)	KR100862930B1 (pl)
AR (1)	AR049929A1 (pl)
AT (1)	ATE404188T1 (pl)
AU (1)	AU2005262558B8 (pl)
BR (1)	BRPI0512569A (pl)
CA (1)	CA2569691C (pl)
CY (1)	CY1110435T1 (pl)
DE (1)	DE602005008970D1 (pl)
DK (1)	DK1768657T3 (pl)
EA (1)	EA011864B1 (pl)
ES (1)	ES2313368T3 (pl)
GE (1)	GEP20084520B (pl)
IL (1)	IL179872A (pl)
LV (1)	LV13564B (pl)
MX (1)	MXPA06014978A (pl)
NO (1)	NO20070408L (pl)
NZ (1)	NZ551955A (pl)
PL (1)	PL1768657T3 (pl)
PT (1)	PT1768657E (pl)
SG (1)	SG140607A1 (pl)
SI (1)	SI1768657T1 (pl)
TW (1)	TWI396532B (pl)
WO (1)	WO2006007314A1 (pl)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3326623A1 (en)	2003-03-14	2018-05-30	University of Washington	Retinoid replacements and opsin agonists and methods for the use thereof
JP2007525496A (ja) *	2004-02-17	2007-09-06	プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ	黄班変性症を含む眼科疾患の管理
EP1722766A2 (en)	2004-02-17	2006-11-22	President And Fellows Of Harvard College	Management of ophthalmologic disorders, including macular degeneration
US7566808B2 (en)	2004-02-17	2009-07-28	President And Fellows Of Harvard College	Management of ophthalmologic disorders, including macular degeneration
KR20140140616A (ko)	2004-06-18	2014-12-09	유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션	시각 이상 치료를 위한 레티날 유도체 및 이를 이용하기 위한 방법
PL1768657T3 (pl)	2004-06-23	2009-01-30	Revision Therapeutics Inc	Sposoby i kompozycje do leczenia stanów ocznych za pomocą pochodnych retinylowych
US20060089411A1 (en) *	2004-08-07	2006-04-27	Gierhart Dennis L	Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin
WO2006033734A2 (en) *	2004-08-18	2006-03-30	Sirion Therapeutics, Inc.	Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders
CN101048139A (zh) *	2004-10-28	2007-10-03	艾德克斯实验室公司	药物活性化合物的控释组合物
KR20070091283A (ko) *	2004-11-04	2007-09-10	시리온 테라퓨틱스, 인크.	레티놀-레티놀 결합단백질(ｒｂｐ)-트랜스타이레틴(ｔｔｒ) 복합체 형성의조절 인자
BRPI0520207A2 (pt) *	2004-12-08	2012-09-25	Revision Therapeutics Inc	uso de uma quantidade eficaz de um primeiro composto, e, medicamento sistemicamente formulado
UA81382C2 (en) *	2005-07-11	2007-12-25		Composition for treating retinol-related diseases by modulation of retinol binding
US8114440B2 (en) *	2005-11-16	2012-02-14	Idexx Laboratories Inc.	Pharmaceutical compositions for the administration of aptamers
US7754679B2 (en) *	2005-11-16	2010-07-13	Idexx Laboratories, Inc.	Pharmaceutical compositions for the administration of aptamers
CN101500594A (zh) *	2006-06-22	2009-08-05	西来昂诊疗公司	通过调节巨蛋白活性治疗眼病的方法和组合物
CA2657015A1 (en) *	2006-07-27	2008-01-31	University Of Florida Research Foundation, Inc.	Opsin stabilizing compounds and methods of use
CA2657238A1 (en) *	2006-07-27	2008-01-31	University Of Florida Research Foundation, Inc.	Compositions and methods for treating or preventing ophthalmic disease
CA2657164A1 (en) *	2006-07-27	2008-01-31	University Of Florida Research Foundation, Inc.	Compositions and methods for treating or preventing ophthalmic light toxicity
US8828960B2 (en) *	2007-07-17	2014-09-09	Idexx Laboratories, Inc.	Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
KR101810381B1 (ko)	2008-02-11	2017-12-19	유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션	연령-관련 망막 기능장애의 치료 및 예방 방법
US8460635B2 (en) *	2008-03-12	2013-06-11	Albert Einstein College Of Medicine Of Yeshiva University	Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents
WO2010008995A2 (en) *	2008-07-14	2010-01-21	Otonomy, Inc.	Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
ES2549916T3 (es) *	2009-05-04	2015-11-03	Acucela, Inc.	Composiciones para usar en el tratamiento de glaucoma o hipertensión ocular
IN2012DN00352A (pl)	2009-06-16	2015-08-21	Bikam Pharmaceuticals Inc
MX2012003220A (es)	2009-09-15	2012-08-03	Quadra Logic Tech Inc	Formulaciones farmaceuticas que comprenden 9-cis-retinil esteres en un vehiculo de lipido.
EP2509596B1 (en)	2009-12-08	2019-08-28	Case Western Reserve University	Gamma aminoacids for treating ocular disorders
WO2011132084A2 (en) *	2010-04-19	2011-10-27	Qlt Inc.	Therapeutic regimen and method for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency
JP6126118B2 (ja)	2011-11-30	2017-05-10	ビカムファーマスーティカルス，インコーポレイテッド	オプシン結合性リガンド、組成物、及び使用方法
US10058616B2 (en) *	2012-02-10	2018-08-28	Tlc Biopharmaceuticals, Inc.	Pharmaceutical compositions to reduce complications of ocular steroid
MX389866B (es)	2012-03-01	2025-03-20	Retinagenix LLC	El uso de 9-cis-retinil acetato para mejorar la funcion visual de un sujeto que padece de perdida de la funcion visual originada por una deficiencia retinoide endogena de 11-cis retinal.
US8877183B2 (en)	2012-06-26	2014-11-04	National Institutes Of Health (Nih)	Methods for treatment of ocular diseases
US9011845B2 (en)	2012-06-26	2015-04-21	Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College	Methods for treatment of inflammatory and infectious viral diseases
US9265458B2 (en)	2012-12-04	2016-02-23	Sync-Think, Inc.	Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en)	2013-03-11	2016-07-05	Sync-Think, Inc.	Optical neuroinformatics
US10092393B2 (en)	2013-03-14	2018-10-09	Allotex, Inc.	Corneal implant systems and methods
WO2015184453A1 (en) *	2014-05-30	2015-12-03	Case Western Reserve University	Retinylamine derivitives for treatment of ocular disorders
RS61504B1 (sr)	2014-10-24	2021-03-31	Takeda Pharmaceuticals Co	Jedinjenja heteroarila za lečenje oftalmičkih bolesti
JP2017538728A (ja) *	2014-12-19	2017-12-28	ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎＩｎｄｕｓｔｒｉｅｓ，Ｉｎｃ．	イオントフォレシスを用いた生物活性分子の眼内送達
US10449090B2 (en)	2015-07-31	2019-10-22	Allotex, Inc.	Corneal implant systems and methods
EP3416622B1 (en) *	2016-02-15	2023-06-28	Kemin Industries, Inc.	Positively charged liposomes as lipophilic molecule carriers
US11395853B2 (en) *	2016-06-23	2022-07-26	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocular conditions
KR102713615B1 (ko)	2016-12-05	2024-10-04	더 잭슨 래보라토리	인간에서의 신경퇴화 및 녹내장에 대한 진단적 마커로서의 망막 및 시신경 내 지방 알갱이
US11931327B2 (en)	2017-07-04	2024-03-19	Daiichi Sankyo Company, Limited	Drug for retinal degenerative disease associated with photoreceptor degeneration
EP3965747A4 (en) *	2019-05-06	2023-06-07	The Regents of the University of California	MATERIALS AND METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
FR3105790B1 (fr) *	2019-12-26	2022-01-14	Biophytis	Composés chimiques ciblant l’œil et leur utilisation dans le traitement de maladies oculaires

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4190594A (en)	1975-11-03	1980-02-26	Johnson & Johnson	Retinoic acid derivatives
US4323581A (en)	1978-07-31	1982-04-06	Johnson & Johnson	Method of treating carcinogenesis
US4665098A (en)	1985-03-28	1987-05-12	Mcneilab, Inc.	Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide having increased bioavailability
US4874795A (en)	1985-04-02	1989-10-17	Yesair David W	Composition for delivery of orally administered drugs and other substances
US4673044A (en) *	1985-08-02	1987-06-16	Eastman Christensen Co.	Earth boring bit for soft to hard formations
US5023252A (en)	1985-12-04	1991-06-11	Conrex Pharmaceutical Corporation	Transdermal and trans-membrane delivery of drugs
US4682663A (en) *	1986-02-18	1987-07-28	Reed Tool Company	Mounting means for cutting elements in drag type rotary drill bit
US4743400A (en)	1986-09-22	1988-05-10	Mcneilab, Inc.	Process for preparing retinoyl chlorides
WO1991001745A1 (en)	1989-07-28	1991-02-21	Sloan-Kettering Institute For Cancer Research	Growth factors containing vitamin a or other retinoids and uses thereof
US5814612A (en)	1991-04-09	1998-09-29	Sloan-Kettering Institute For Cancer Research	Retinol derivatives and uses thereof
US6506917B1 (en)	1991-12-18	2003-01-14	The Salk Institute For Biological Studies	Compounds and compositions useful for modulation of processes mediated by RXR
US6050354A (en) *	1992-01-31	2000-04-18	Baker Hughes Incorporated	Rolling cutter bit with shear cutting gage
US5314909A (en)	1993-03-17	1994-05-24	Merck & Co., Inc.	Use of non-steroidal antiiflammatory agents in macular degeneration
US5399757A (en)	1993-07-20	1995-03-21	Ortho Pharmaceutical Corporation	Process for the preparation of N-(4-hydroxyphenyl)-retinamide
US5824685A (en)	1995-02-01	1998-10-20	The Johns Hopkins University School Of Medicine	Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
US5596011A (en)	1995-04-06	1997-01-21	Repine; Karen M.	Method for the treatment of macular degeneration
US5702357A (en) *	1995-06-07	1997-12-30	Cobe Laboratories, Inc.	Extracorporeal blood processing methods and apparatus
US5706906A (en) *	1996-02-15	1998-01-13	Baker Hughes Incorporated	Superabrasive cutting element with enhanced durability and increased wear life, and apparatus so equipped
US5758733A (en) *	1996-04-17	1998-06-02	Baker Hughes Incorporated	Earth-boring bit with super-hard cutting elements
US5846220A (en)	1996-04-30	1998-12-08	Medtronic, Inc.	Therapeutic method for treatment of Alzheimer's disease
US6034211A (en)	1996-06-03	2000-03-07	Kelly; Jeffery W.	β-sheet nucleating peptidomimetics
GB9621217D0 (en) *	1996-10-11	1996-11-27	Camco Drilling Group Ltd	Improvements in or relating to preform cutting elements for rotary drill bits
AU5727798A (en)	1996-12-23	1998-07-17	Texas A & M University, The	Anti-amyloidogenic agents
US5955305A (en)	1997-04-28	1999-09-21	Incyte Pharmaceuticals, Inc.	Human retinoid binding protein
US5776915A (en)	1997-08-12	1998-07-07	Clarion Pharmaceuticals Inc.	Phosphocholines of retinoids
CZ300929B6 (cs)	1997-08-15	2009-09-16	Duke University	Sloucenina pro použití pri lécení nebo prevenci estrogenem stimulované rakoviny
AU3980499A (en)	1998-05-11	1999-11-29	Endowment for Research in Human Biology, Inc., The	Use of neomycin for treating angiogenesis-related diseases
US7229961B2 (en)	1999-08-24	2007-06-12	Cellgate, Inc.	Compositions and methods for enhancing drug delivery across and into ocular tissues
US6669951B2 (en)	1999-08-24	2003-12-30	Cellgate, Inc.	Compositions and methods for enhancing drug delivery across and into epithelial tissues
EP1216221A2 (en)	1999-09-14	2002-06-26	Ligand Pharmaceuticals Incorporated	Rxr modulators with improved pharmacologic profile
WO2001038344A2 (en)	1999-11-23	2001-05-31	Gerhart Graupner	Modulation of signal transduction
US20020031539A1 (en)	2000-08-30	2002-03-14	The Brigham And Women's Hospital, Inc.	Oxidized forms of retinoic acid as ligands for peroxisome proliferator activated receptor gamma
WO2002032413A2 (en)	2000-10-17	2002-04-25	Board Of Regents, The University Of Texas System	A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes
US6408958B1 (en) *	2000-10-23	2002-06-25	Baker Hughes Incorporated	Superabrasive cutting assemblies including cutters of varying orientations and drill bits so equipped
WO2002058689A1 (en)	2000-12-05	2002-08-01	Childrens Hospital Los Angeles	Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
US20030032078A1 (en)	2001-01-23	2003-02-13	Board Of Regents, The University Of Texas System	Methods and compositions for the treatment of macular and retinal degenerations
JP2004526807A (ja)	2001-05-29	2004-09-02	ケビジェンカンパニーリミテッド	新規のレチノイド誘導体及びその製造方法並びにその化合物を含有する抗癌剤組成物
DE60208792T2 (de)	2001-06-22	2006-08-31	Merck & Co., Inc.	Tyrosin-kinase inhibitoren
AU2002316593A1 (en)	2001-07-06	2003-01-21	The Ohio State University Research Foundation	Solid phase synthesis of arylretinamides
WO2003007944A1 (en)	2001-07-20	2003-01-30	Qlt, Inc.	Treatment of macular edema with photodynamic therapy
US20030229062A1 (en)	2001-12-07	2003-12-11	The Regents Of The University Of California	Treatments for age-related macular degeneration (AMD)
US20040014131A1 (en)	2002-07-09	2004-01-22	Pfizer Inc.	Assay methods
AU2003301813A1 (en)	2002-10-30	2004-06-07	University Of Kentucky Research Foundation	Methods and animal model for analyzing age-related macular degeneration
US7354574B2 (en)	2002-11-07	2008-04-08	Advanced Ocular Systems Limited	Treatment of ocular disease
JP2006514094A (ja)	2002-11-29	2006-04-27	ゲーペーツェーバイオテックアクチェンゲゼルシャフト	Ｃ型肝炎ウイルス感染に対して有用な製剤
SI21392A (sl)	2002-12-24	2004-06-30	Vinko Kunc	Postopek za avtomatsko nastavitev ojačenja izpraševalnikovega sprejemnika v brezkontaktnem identifikacijskem sistemu
CA2513260C (en)	2003-01-31	2013-01-08	Childrens Hospital Los Angeles	Oral compositions of fenretinide having increased bioavailability and methods of using the same
FI20030426L (fi)	2003-03-24	2004-09-25	Tomi Jaervinen	Syklodekstriinikompleksit
US7178609B2 (en) *	2003-08-19	2007-02-20	Baker Hughes Incorporated	Window mill and drill bit
JP4869942B2 (ja)	2003-12-11	2012-02-08	ベス・イスラエル・ディーコネス・メディカル・センター，インコーポレイテッド	インスリン感受性／抵抗性、糖尿病および肥満におけるｒｂｐ４
WO2005077176A1 (en)	2004-02-11	2005-08-25	The Trustees Of Columbia University In The City Of New York	Anthocyanin compounds and methods of use thereof
US7566808B2 (en)	2004-02-17	2009-07-28	President And Fellows Of Harvard College	Management of ophthalmologic disorders, including macular degeneration
EP1722766A2 (en) *	2004-02-17	2006-11-22	President And Fellows Of Harvard College	Management of ophthalmologic disorders, including macular degeneration
NZ550340A (en)	2004-03-17	2010-08-27	Lars Michael Larsen	Prevention of retinopathy by inhibition of the visual cycle using a retinoid
KR20140140616A (ko)	2004-06-18	2014-12-09	유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션	시각 이상 치료를 위한 레티날 유도체 및 이를 이용하기 위한 방법
PL1768657T3 (pl)	2004-06-23	2009-01-30	Revision Therapeutics Inc	Sposoby i kompozycje do leczenia stanów ocznych za pomocą pochodnych retinylowych
US7286860B2 (en)	2004-07-23	2007-10-23	Dyna Llc	Systems and methods for a comfortable wireless communication device
WO2006033734A2 (en)	2004-08-18	2006-03-30	Sirion Therapeutics, Inc.	Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders
KR20070091283A (ko)	2004-11-04	2007-09-10	시리온 테라퓨틱스, 인크.	레티놀-레티놀 결합단백질(ｒｂｐ)-트랜스타이레틴(ｔｔｒ) 복합체 형성의조절 인자
BRPI0520207A2 (pt)	2004-12-08	2012-09-25	Revision Therapeutics Inc	uso de uma quantidade eficaz de um primeiro composto, e, medicamento sistemicamente formulado
UA81382C2 (en)	2005-07-11	2007-12-25		Composition for treating retinol-related diseases by modulation of retinol binding

2005
- 2005-06-06 PL PL05758777T patent/PL1768657T3/pl unknown
- 2005-06-06 SI SI200530415T patent/SI1768657T1/sl unknown
- 2005-06-06 SG SG200801546-3A patent/SG140607A1/en unknown
- 2005-06-06 JP JP2007518098A patent/JP4855396B2/ja not_active Expired - Fee Related
- 2005-06-06 DE DE602005008970T patent/DE602005008970D1/de not_active Expired - Lifetime
- 2005-06-06 CA CA2569691A patent/CA2569691C/en not_active Expired - Fee Related
- 2005-06-06 EP EP05758777A patent/EP1768657B1/en not_active Expired - Lifetime
- 2005-06-06 MX MXPA06014978A patent/MXPA06014978A/es active IP Right Grant
- 2005-06-06 KR KR1020077001270A patent/KR100862930B1/ko not_active Expired - Fee Related
- 2005-06-06 AT AT05758777T patent/ATE404188T1/de active
- 2005-06-06 PT PT05758777T patent/PT1768657E/pt unknown
- 2005-06-06 BR BRPI0512569-3A patent/BRPI0512569A/pt not_active IP Right Cessation
- 2005-06-06 WO PCT/US2005/020080 patent/WO2006007314A1/en not_active Ceased
- 2005-06-06 AU AU2005262558A patent/AU2005262558B8/en not_active Ceased
- 2005-06-06 EP EP10181656A patent/EP2277516A1/en not_active Withdrawn
- 2005-06-06 DK DK05758777T patent/DK1768657T3/da active
- 2005-06-06 NZ NZ551955A patent/NZ551955A/en not_active IP Right Cessation
- 2005-06-06 EP EP08014275A patent/EP2025336A1/en not_active Withdrawn
- 2005-06-06 EA EA200700109A patent/EA011864B1/ru not_active IP Right Cessation
- 2005-06-06 GE GEAP20059816A patent/GEP20084520B/en unknown
- 2005-06-06 ES ES05758777T patent/ES2313368T3/es not_active Expired - Lifetime
- 2005-06-10 US US11/150,641 patent/US8314152B2/en not_active Expired - Fee Related
- 2005-06-21 AR ARP050102545A patent/AR049929A1/es not_active Application Discontinuation
- 2005-06-22 TW TW094120880A patent/TWI396532B/zh not_active IP Right Cessation
2006
- 2006-12-06 IL IL179872A patent/IL179872A/en not_active IP Right Cessation
2007
- 2007-01-19 LV LVP-07-05A patent/LV13564B/lv unknown
- 2007-01-22 NO NO20070408A patent/NO20070408L/no not_active Application Discontinuation
2008
- 2008-11-12 CY CY20081101287T patent/CY1110435T1/el unknown
2010
- 2010-04-21 US US12/764,764 patent/US8410168B2/en not_active Expired - Fee Related
2011
- 2011-05-27 US US13/118,330 patent/US20110294891A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EA011864B1 (ru)	2009-06-30
IL179872A0 (en)	2007-05-15
ES2313368T3 (es)	2009-03-01
US8410168B2 (en)	2013-04-02
CY1110435T1 (el)	2015-04-29
EP2277516A1 (en)	2011-01-26
HK1107671A1 (en)	2008-04-11
EP2025336A1 (en)	2009-02-18
BRPI0512569A (pt)	2008-03-25
DE602005008970D1 (de)	2008-09-25
PT1768657E (pt)	2008-11-25
NZ551955A (en)	2010-08-27
MXPA06014978A (es)	2007-04-25
IL179872A (en)	2013-01-31
US20060167088A1 (en)	2006-07-27
SG140607A1 (en)	2008-03-28
CA2569691C (en)	2010-08-17
NO20070408L (no)	2007-03-20
US8314152B2 (en)	2012-11-20
SI1768657T1 (sl)	2009-02-28
EP1768657A1 (en)	2007-04-04
AU2005262558A1 (en)	2006-01-19
US20110294891A1 (en)	2011-12-01
AU2005262558B8 (en)	2008-04-10
EP1768657B1 (en)	2008-08-13
KR20070074541A (ko)	2007-07-12
AU2005262558B2 (en)	2008-03-20
GEP20084520B (en)	2008-10-27
TW200612891A (en)	2006-05-01
WO2006007314A1 (en)	2006-01-19
TWI396532B (zh)	2013-05-21
DK1768657T3 (da)	2008-12-01
JP4855396B2 (ja)	2012-01-18
AR049929A1 (es)	2006-09-13
EA200700109A1 (ru)	2007-10-26
LV13564B (en)	2008-02-20
KR100862930B1 (ko)	2008-10-13
JP2008504257A (ja)	2008-02-14
US20100298443A1 (en)	2010-11-25
CA2569691A1 (en)	2006-01-19
ATE404188T1 (de)	2008-08-15

Publication	Publication Date	Title
SI1768657T1 (sl)	2009-02-28	Postopki in sestavki za zdravljenje oftalmičnih obolenj z derivati retinila
TWI369996B (en)	2012-08-11	Ophthalmic compositions and methods for treating eyes
ZA200700918B (en)	2008-10-29	Compositions and methods for treating eye disorders and conditions
PT2374472T (pt)	2018-08-08	Composições e métodos para o tratamento de afeções oftalmológicas
EP1742641A4 (en)	2013-04-03	METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF RETINA DISEASES
IL186895A0 (en)	2008-02-09	Methods for treating eye conditions
EP1715799A4 (en)	2010-06-02	METHOD FOR TREATING GLAUCOMA
PT1755391E (pt)	2016-02-03	Métodos e composições para o tratamento de neuropatias
EP1737482A4 (en)	2010-09-15	COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
IL182837A0 (en)	2008-04-13	Methods, assays and compositions for treating retinol-related diseases
IL183535A0 (en)	2007-09-20	Rubber formulation and methods for manufacturing same
ZA200703827B (en)	2008-08-27	New pyridothlenopyrimidine derivates
GB0613730D0 (en)	2006-08-23	Methods and compositions for treating opthalmic conditions via serum retinol modulation
EP1877840A4 (en)	2010-05-19	OPHTHALMIC APPARATUS AND METHODS
ZA200700596B (en)	2008-06-25	Methods and compositions for treating ophthalmic conditions with retinyl derivatives
PL2374472T3 (pl)	2018-11-30	Kompozycje i sposoby leczenia zaburzeń okulistycznych
ZA200704428B (en)	2008-05-28	Rubber formulation and methods for manufacturing same
AU2012258341A1 (en)	2012-12-20	Methods and compositions for treating conditions
HK1103984A (en)	2008-01-04	Compositions and methods for treating eye disorders and conditions
HK1096031A (en)	2007-05-25	Compositions and methods for treating contracture
GB0505077D0 (en)	2005-04-20	Ophthalmic apparatus and method
GB0401399D0 (en)	2004-02-25	Ophthalmic device
HK1107578A (en)	2008-04-11	Compositions and methods for treating hyperproliferative disorders
AU158396S (en)	2005-11-24	Sunglasses
PL376747A1 (pl)	2007-03-05	Nowe kopolimery organiczno-nieorganiczne oraz sposób ich wytwarzania